2BB score and signals
Atrium Therapeutics’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 43 | Moderate |
| Momentum | 61 | Improving |
| Financial strength | 46 | Normal |
| Quality | 60 | Strong |
| Risk | 42 | Moderate |
Atrium Therapeutics (RNA) Stock Score & Signals
Atrium Therapeutics (RNA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry. Its current 2BB score is 51 out of 100.
Company facts
| Founded | 2025 |
| Employees | 47 |
| 52-week range | $11.13 – $73.06 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-05-14 | -0.97 | -1.0605 | $19.64M | $2.02M |